Related Experiment Video
Updated: May 18, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Analgesic and sedative drugs in newborns requiring respiratory support
Gina Ancora1, Elisabetta Garetti, Anna Pirelli
1UO Neonatal Intensive Care, Ospedale Infermi Rimini, Italy. gina.ancora@auslrn.net
Insights
Pain management is crucial for infants on respiratory support to reduce complications. This review covers drug evidence and practical pain control strategies for neonates receiving ventilation.
Area of Science:
- Neonatal care
- Pediatric critical care
- Pharmacology
Background:
- Infants requiring respiratory assistance often experience pain from their condition or the ventilation process.
- Effective pain management in neonates receiving respiratory support is essential for minimizing adverse outcomes and improving recovery.
- Understanding pain mechanisms and appropriate interventions is vital in neonatal intensive care units.
Purpose of the Study:
- To review the scientific evidence on analgesic and sedative drug use in neonates undergoing mechanical ventilation.
- To provide practical recommendations for pain management strategies in this vulnerable patient population.
- To enhance the quality of care for infants receiving respiratory support by addressing pain.
Main Methods:
- Systematic review of existing scientific literature on pain management in ventilated neonates.
- Analysis of pharmacological agents commonly used for pain and sedation during mechanical ventilation.
- Synthesis of evidence regarding efficacy and safety of different pain control methods.
Main Results:
- Specific drug classes and agents are identified as effective for managing pain and procedural discomfort in neonates on ventilators.
- Evidence supports the use of certain sedatives and analgesics to reduce physiological stress and improve tolerance to ventilation.
- Optimal dosing and monitoring strategies are discussed based on current research.
Conclusions:
- Pharmacological interventions play a significant role in mitigating pain and improving outcomes for infants on respiratory support.
- Evidence-based pain management protocols are necessary for optimizing neonatal respiratory care.
- Further research may refine optimal drug choices and non-pharmacological adjuncts for neonatal pain management during ventilation.
Abstract:
Infants receiving respiratory assistance may feel pain due to underlying disease or ventilation itself. Pain control during neonatal respiratory care reduces morbidity. This article summarizes the main scientific evidence about the use of drugs during ventilatory assistance, and provides some practical suggestions on pain management in neonates with respiratory support.
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

